Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Cash Flows from Operating Activities:
Net income	$ 3,585	$ 1,748
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,049	872
Provision for bad debts	485	431
Stock issued for costs and expenses	220	247
Compensatory element of stock issuances	34	118
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivable(s)	(68)	(469)
Notes receivable	42	(291)
Costs and estimated earnings in excess of billings on uncompleted contracts	(983)	5
Inventories	(1,406)	70
Prepaid expenses and other current assets	82	259
Other assets	38	(119)
Advances and notes to related medical practices		83
Increase (decrease) in operating liabilities, net:
Accounts payable	(189)	(694)
Other current liabilities	(312)	1,328
Customer advances	(943)	(364)
Billings in excess of costs and estimated earnings on uncompleted contracts	732	(1,611)
Other liabilities	(8)	19
Due to related medical practices	1	(296)
Income Tax Payable	(75)
Net cash provided by operating activities	2,284	1,336
Cash Flows from Investing Activities:
Sales of Marketable Securities	(1)	(1)
Purchases of property and equipment	(380)
Costs of capitalized software development		(66)
Cost of patents	(75)	(82)
Net cash used in investing activities	(456)	(149)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(646)	(597)
Distributions to non controlling interests	(563)
Repayment of notes receivable from employee stockholders	41	72
Net cash used in financing activities	(1,168)	(525)
Net Increase (Decrease) in Cash and Cash Equivalents	660	662
Cash and Cash Equivalents - Beginning of Period	9,251	1,299
Cash and Cash Equivalents - End of Period	$ 9,911	$ 1,961